Tracer library / [18F]BTK-1

[18F]BTK-1

Also written as [18F]BTK-1; [F-18]BTK-1

Radionuclide: F-18 t½ 109.77 min
Modality: PET
Production route: —
Stage: Preclinical
Syntheses indexed: 1

Lymphoma Dosimetry and biodistribution studies Receptor expression phenotyping

What it is

Compound class: —
Target / mechanism: Bruton's tyrosine kinase (BTK) PMID 35482146
Clinical application: B cell malignancies and autoimmune disorders PMID 35482146
Theranostic pair: —

Published syntheses

Module	Cassette	Purification	Yield %	RCP %	Precursor / supplier	Source
TRACERlab FX FN GE HealthCare	—	—	6% decay-corrected	99%	—	35482146 2022 Mol Imaging Biol on a GE FX-FN TracerLab synthesis module - 6% decay-corrected radiochemical yield

Need this precursor?We can point you to suppliers for [18F]BTK-1, or handle the enquiry for you.

Get in touch

Quality control Preliminary - inferred from compound class

Ph. Eur. monograph: not verified No Ph. Eur. check is recorded for this entry.
USP monograph: not verified No USP check is recorded for this entry.

AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity

How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]BTK-1.

Get in touch

Notes

Added from reverse module search (stage 6); 1 article(s) with F-18.